Financhill
Back

Greif, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
50

GEF
Greif, Inc.

Last Price:
$69.03
Seasonality Move:
-1.22%
Sell
46

NKTR
Nektar Therapeutics

Last Price:
$43.30
Seasonality Move:
6.44%
Sell
50
Greif, Inc. (GEF) is a Sell

Is Greif, Inc. a Buy, Sell or Hold?

  • The current Greif, Inc. [GEF] share price is $68.71. The Score for GEF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GEF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GEF Stock Price Chart

What is Greif, Inc.'s stock price today?

  • The Greif, Inc. share price today is $68.71
    The current trend is moderately bullish and GEF is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $46.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

GEF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.21 Buy
Relative Strength Index (14 RSI): 64.15 Buy
Chaikin Money Flow: -560449 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.34 - 68.46) Buy
Bollinger Bands (100): (58.8 - 66.22) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.95 Sell
Relative Strength Index (14 RSI): 38.83 Sell
Chaikin Money Flow: 857593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.69 - 61.39) Sell
Bollinger Bands (100): (34.99 - 62.73) Sell

GEF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.97 Sell
20-day SMA: 66.52 Buy
50-day SMA: 62.06 Buy
200-day SMA: 60.64 Buy
8-day EMA: 68.71 Sell
20-day EMA: 66.59 Buy
50-day EMA: 63.88 Buy
200-day EMA: 62.05 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.29 Sell
20-day SMA: 55.51 Sell
50-day SMA: 57.37 Sell
200-day SMA: 31.53 Buy
8-day EMA: 49.58 Sell
20-day EMA: 53.48 Sell
50-day EMA: 54.29 Sell
200-day EMA: 38.34 Buy

Greif, Inc. Earnings Growth & GEF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $1.18 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

Greif, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):